Baxter International Inc. (BAX)
NYSE: BAX · IEX Real-Time Price · USD
32.85
-0.21 (-0.64%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Baxter International Market Cap
Baxter International has a market cap or net worth of $16.74 billion as of July 2, 2024. Its market cap has decreased by -26.53% in one year.
Market Cap
16.74B
Enterprise Value
27.88B
1-Year Change
-26.53%
Ranking
Category
Stock Price
$32.85
Market Cap Chart
Since December 1, 1998, Baxter International's market cap has decreased from $18.88B to $16.74B, a decrease of -11.32%. That is a compound annual growth rate of -0.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 16.85B | -14.10% |
Dec 29, 2023 | 19.61B | -23.67% |
Dec 30, 2022 | 25.70B | -40.22% |
Dec 31, 2021 | 42.98B | 4.86% |
Dec 31, 2020 | 40.99B | -3.99% |
Dec 31, 2019 | 42.69B | 21.89% |
Dec 31, 2018 | 35.03B | -0.55% |
Dec 29, 2017 | 35.22B | 46.03% |
Dec 30, 2016 | 24.12B | 15.57% |
Dec 31, 2015 | 20.87B | -47.46% |
Dec 31, 2014 | 39.72B | 5.24% |
Dec 31, 2013 | 37.74B | 3.07% |
Dec 31, 2012 | 36.62B | 31.26% |
Dec 30, 2011 | 27.90B | -5.42% |
Dec 31, 2010 | 29.50B | -16.62% |
Dec 31, 2009 | 35.38B | 6.44% |
Dec 31, 2008 | 33.24B | -9.71% |
Dec 31, 2007 | 36.81B | 21.24% |
Dec 29, 2006 | 30.36B | 29.31% |
Dec 30, 2005 | 23.48B | 10.27% |
Dec 31, 2004 | 21.29B | 14.31% |
Dec 31, 2003 | 18.63B | 12.13% |
Dec 31, 2002 | 16.61B | -47.53% |
Dec 31, 2001 | 31.66B | 21.88% |
Dec 29, 2000 | 25.98B | 42.15% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Molina Healthcare | 17.42B |
The Cooper Companies | 17.38B |
Hologic | 17.33B |
Waters | 17.21B |
Labcorp Holdings | 17.15B |
Illumina | 16.63B |
Genmab | 16.37B |
BioMarin Pharmaceutical | 15.63B |